News
ARC Therapies advances gut microbiome research with YB328 toward clinical application: Tokyo Thursday, August 21, 2025, 17:00 Hrs [IST] ARC Therapies Inc with head office at Shinj ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback